Seer, Inc. Faces Delisting Concerns, Votes on Key Matters

Ticker: SEER · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1726445

Seer, Inc. 8-K Filing Summary
FieldDetail
CompanySeer, Inc. (SEER)
Form Type8-K
Filed DateJul 8, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, corporate-governance

TL;DR

Seer's stock might get delisted, and they're voting on important stuff.

AI Summary

Seer, Inc. filed an 8-K on July 8, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also submitted matters to a vote of security holders. The company, formerly known as Seer Biosciences, Inc., is incorporated in Delaware and headquartered in Redwood City, California.

Why It Matters

This filing indicates potential issues with Seer, Inc.'s continued listing on an exchange, which could impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status and investor confidence.

Key Numbers

  • 001-39747 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 82-1153150 — I.R.S. Employer Identification No. (Tax identification number for the company.)

Key Players & Entities

  • Seer, Inc. (company) — Registrant
  • Seer Biosciences, Inc. (company) — Former company name
  • Delaware (jurisdiction) — State of incorporation
  • Redwood City, California (location) — Principal executive offices
  • July 7, 2025 (date) — Date of earliest event reported
  • July 8, 2025 (date) — Date of report

FAQ

What specific listing rule or standard has Seer, Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Seer, Inc. has failed to satisfy, only that a notice has been issued.

What matters are being submitted to a vote of security holders?

The filing indicates that matters are being submitted to a vote, but does not detail what those specific matters are.

When was Seer, Inc. formerly known as Seer Biosciences, Inc. and when did the name change occur?

The company was formerly known as Seer Biosciences, Inc., and the date of the name change was December 26, 2017.

What is the address of Seer, Inc.'s principal executive offices?

The principal executive offices are located at 3800 Bridge Parkway, Suite 102, Redwood City, California 94065.

What is the SIC code for Seer, Inc.?

The Standard Industrial Classification (SIC) code for Seer, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Seer, Inc. (SEER).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.